Cookies are used for the functionality of our web site. For more information
please see our Privacy policy or Ok thanks

Satellite sessions programme WFPH2020


WCPH2020 offers a satellite programme of sponsored sessions. Sessions are held from Wednesday until Friday from 13:15 – 14:15 CET. Satellite sessions are free to attend, separate registration is not necessary.

Protecting the most vulnerable against 2020-21 influenza: the opening move

Wednesday 14 October, 13:15– 14:15 CET

Organizer: Seqirus

Currently there is an official start to influenza surveillance activities in several countries of the Northern Hemisphere. The 2020-21 influenza season is expected to be exceptional, as influenza virus will co-circulate with the SARS-CoV-19. In this Symposium different stakeholders are invited to discuss the most appropriate innovative tactics to minimize the burden of both influenza and COVID-19 from the global public health perspective. 

The 2020-21 influenza season begins. What should we expect from the increased vaccine demand?
Caterina Rizzo, Bambino Gesù Children's Hospital, Rome, Italy

Beyond the “one-size-fits-all” approach: a right vaccine to a right patient
Paolo Bonanni, University of Florence, Italy

Why to invest in preventive healthcare? The role of HTA in guiding effective influenza vaccination policies.
Chiara de Waure, University of Perugia, Italy

 

True burden of influenza and prospects for prevention in older adults

Wednesday 14 October, 19:15–19:50 CET

Organizer: Sanofi Pasteur

The Flu symposium entitled "true burden of influenza and prospects for prevention in older adults" is structured in two parts of which the first part, related by Professor Gaetan Gavazzi, focuses attention on the burden of influenza under the tip of the iceberg and its cardiovascular complications in particular in the elderly population; the second part, managed by Dr. Sandrine Samson, enhances the excellent characteristics of the new high-dose vaccine which represents an optimal solution for the prevention of influenza and its complications with its indication currently valid for the elderly from 65 years of age.

Indirect clinical impact of Influenza and COVID-19 in older populations
Gaëtan Gavazzi - MD, PhD, Professor of Geriatrics, University Hospital of Grenoble-Alpes, France

High-dose influenza vaccine benefits for older adults
Sandrine Samson - Global Medical Expert, Sanofi Pasteur, France

 

Defeating meningococcal meningitis is in our hands! How policy makers are successfully implementing routine vaccination campaigns across all ages 

Thursday 15 October, 13:15-14:15 CET

Organizer: Sanofi Pasteur 

In a world eagerly waiting for a vaccine that will allow us to resume normal life, join Sanofi Pasteur for an interactive session with an expert panel. Experts will be looking at how countries are leading the way in implementing routine vaccination campaigns as a way to protect their populations of all ages against meningococcal meningitis, a largely vaccine preventable disease.

Moderator: Gary Finnegan – Editor, Vaccines Today; Board Member of the Coalition on Life-Course Immunisation

Panellists:
Elena Moya – President of the AEM (Asociación Española contra la Meningitis) and Co-ordinator for Europe and Africa, Confederation of Meningitis Organisations
Paolo Bonanni – Professor of Hygiene in the Faculty of Medicine, University of Florence, Italy
Pablo Bonvehí – Head of the Infectious Diseases and Infection Control Section at University Hospital CEMIC, Argentina

 

Operational service on climate change impacts to public health 

Thursday 15 October, 13:15-13:45 CET

Organizer: ECMWF Copernicus Services

Human health is strongly impacted by climate change. To monitor and project future effects, the C3S European Health Service provides climate-health indicators concerning heat and cold stress, vector-borne disease, and allergenic pollen

Moderator and Speaker:
Julie Berkcmans - R&D Climate, VITO 

Speakers:
Francesca de'Donato - Senior Researcher Biometeorologist, Department of Epidemiology, Lazio Regional Health Service - ASL ROMA 1
Páldy Anna National Institute of Environmental Health deputy director, National Institute of Environmental Health

 

Eye Health: 2020 Year of Vision - Addressing eye health needs in a post-COVID-19 World

Friday 16 October, 13:15-14:15 CET

Organizer: European Coalition for Vision

The International Agency for the Prevention of Blindness (IAPB) Vision 2020 – right to sight initiative launched in 1999 to eliminate avoidable blindness by 2020 has done a lot of good but has not eliminated avoidable blindness as originally hoped.   Ageing populations and changes in age structure have outpaced the impact of interventions to reduce the prevalence of eye disease, in particular cataract, uncorrected refractive error, glaucoma and macular degeneration.  Over the last 3 decades the numbers of blind people have increased by 50% globally and those with moderate/severe vision impairment by 90%.

Speaker: Rupert Bourne

 

Public health responses and government measures to combat the COVID-19 pandemic in China

Friday 16 October, 13:15-14:15 CET

Organizer: Chinese Preventive Medicine Association

What are the inspirations to the world from China’s experiences on COVID-19 prevention and control? How to develop effective international cooperation on public health?

Chairperson: Liang Xiaofeng - Chinese Preventive Medicine Association, China

Speakers: Ren Minghui - Assistant Director-General, Universal Health Coverage / Communicable and Noncommunicable Diseases, WHO

Fangcang shelter hospitals - a novel concept for responding to public health emergencies
Wang Chen - Chinese Academy of Medical Science & Peking Union Medical College, China

Active case finding with case management - the key to tackling the COVID -19 pandemic
Li Zhongjie - National Institute for Communicable Disease Control and Prevention, China

Progress in COVID-19 vaccine research in China
Yang Xiaoming - National BIOTEC Group Company Limited, China

Panellists:

  • Han Tieru – Former WHO Deputy Regional Director for the Western Pacific
  • Guo Yan – School of Public Health, Peking University, China
  • Zhou Xiaonong - National Institute of Parasitic Diseases, China
  • Dong Xiaoping –The Center for Global Public Health, China